✦ LIBER ✦

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

✍ Scribed by Goede, Valentin; Fischer, Kirsten; Busch, Raymonde; Engelke, Anja; Eichhorst, Barbara; Wendtner, Clemens M.; Chagorova, Tatiana; de la Serna, Javier; Dilhuydy, Marie-Sarah; Illmer, Thomas; Opat, Stephen; Owen, Carolyn J.; Samoylova, Olga; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Döhner, Hartmut; Langerak, Anton W.; Ritgen, Matthias; Kneba, Michael; Asikanius, Elina; Humphrey, Kathryn; Wenger, Michael; Hallek, Michael

Book ID: 121714488
Publisher: Massachusetts Medical Society
Year: 2014
Tongue: English
Weight: 650 KB
Volume: 370
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa1313984

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoimmunotherapy with GA101 plus chlor

Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in

✍ Goede, V; Fischer, K; Busch, R; Jaeger, U; Dilhuydy, M-S; Wickham, N; De Guibert 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 335 KB

5.37 Myelodysplastic Syndrome and Acute

5.37 Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Fludarabine plus Cyclophosphamide plus Rituximab in Patients with CLL

✍ K. Maloum; C. Settegrana; J. Dupuis; A. Brion; J. Zini; B. Dreyfus; F. Cymbalist 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 90 KB

Comparative pharmacokinetic and metaboli

Comparative pharmacokinetic and metabolic study with chlorambucil plus prednisolone versus prednimustine in patients with lymphomas and mammary carcinoma

✍ B. Musch; U. Vahlensieck; H.P. Rüb; M. Malek; U. Loos; J. Hartlapp; Th. Hügl 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Safety and efficacy of peginterferon alp

Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease

✍ Emanuele Durante-Mangoni; Domenico Iossa; Daniela Pinto; Lucia De Vincentiis; En 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

6004 ORAL Oblimersen plus fludarabine/cy

6004 ORAL Oblimersen plus fludarabine/cyclophosphamide (FC) significantly increases complete remission and overall survival in non-refractory patients (Pts) with relapsed chronic lymphocytic leukemia (CLL): results from a prospective randomized phase 3 trial

✍ Novick, S.; O'Brien, S.; Moore, J.; Boyd, T.; Ding, L.; Rai, K. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB